, melanoma patients is followed by increased frequencies of additional Melan-A-specifi c T cells, J. Immunol, vol.175, pp.4797-4805
Infusion of Melan-A/Mart-1 specifi c tumor-infi ltrating lymphocytes enhanced relapse-free survival of melanoma patients, Cancer Immunol. Immunother, vol.56, pp.515-526, 2007. ,
Adoptive T cell therapy using antigen-specifi c CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor eff ect of transferred T cells, Proc. Natl. Acad. Sci. USA, vol.99, pp.16168-16173, 2002. ,
Randomized trial of adoptive transfer of melanoma tumor-infi ltrating lymphocytes as adjuvant therapy for stage III melanoma, Cancer Immunol. Immunother, vol.51, pp.539-546, 2002. ,
Therapeutic effi cacy of melanoma-reactive TIL injected in stage III melanoma patients, Cancer Immunol. Immunother, vol.51, pp.532-538, 2002. ,
Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infi ltrating lymphocytes as adjuvant therapy for stage III melanoma, Cancer Immunol. Immunother, vol.56, pp.1853-1860, 2007. ,
Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infi ltrating lymphocytes (TIL): implications for immunotherapy, Eur. J. Immunol, vol.31, pp.2007-2015, 2001. ,
? v ? 3-dependent cross-presentation of matrix metalloproteinase -2 by melanoma cells gives rise to a new tumor antigen, J. Exp. Med, vol.202, pp.61-72, 2005. ,
, Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences, Proc. Natl. Acad. Sci. USA, vol.99, pp.16899-16903, 2002.
The sequence of the human genome, Science, vol.291, pp.1304-1351, 2001. ,
URL : https://hal.archives-ouvertes.fr/hal-00465088
PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting, Cancer Immunol. Immunother, vol.57, pp.185-195, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00167752
Three proteins defi ne a class of human histone deacetylases related to yeast Hda1p, Proc. Natl. Acad. Sci. USA, vol.96, pp.4868-4873, 1999. ,
Human T cell responses against melanoma, Annu. Rev. Immunol, vol.24, pp.175-208, 2006. ,
A new gene coding for a diff erentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas, J. Exp. Med, vol.180, pp.35-42, 1994. ,
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas, J. Exp. Med, vol.178, pp.489-495, 1993. ,
Recognition of a ubiquitous self antigen by prostate cancer-infi ltrating CD8+ T lymphocytes, Science, vol.319, pp.215-220, 2008. ,
Promoter-dependent mechanism leading to selective hypomethylation within the 5 ? region of gene MAGE-A1 in tumor cells, Mol. Cell. Biol, vol.24, pp.4781-4790, 2004. ,
, MLANA/MART1 and SILV, 2003.
, de Recherche 26 for the production of HLA -peptide complexes, and C. Gratas for helpful assistance in qPCR experiments
Identifi cation of a human melanoma antigen recognized by tumor-infi ltrating lymphocytes associated with in vivo tumor rejection, Proc. Natl. Acad. Sci. USA, vol.91, pp.6458-6462, 1994. ,
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma, Science, vol.254, pp.1643-1647, 1991. ,
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes, J. Exp. Med, vol.179, pp.921-930, 1994. ,
A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma, Science, vol.269, pp.1281-1284, 1995. ,
Effi cient identifi cation of novel HLA-A(*)0201 -presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis, J. Exp. Med, vol.193, pp.73-88, 2001. ,
A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene, J. Exp. Med, vol.183, pp.1173-1183, 1996. ,
A processed pseudogene codes for a new antigen recognized by a CD8 + T cell clone on melanoma, J. Exp. Med, vol.191, pp.1617-1624, 2000. ,
Clonal expansion of Melan A-specifi c cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides, Int. J. Cancer, vol.86, pp.538-547, 2000. ,
Peptide-specifi c CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1, Int. J. Cancer, vol.98, pp.376-388, 2002. ,
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes, Science, vol.298, pp.850-854, 2002. ,
Phase I study of adoptive T-cell therapy using antigen-specifi c CD8+ T cells for the treatment of patients with metastatic melanoma, J. Clin. Oncol, vol.24, pp.5060-5069, 2006. ,
Survival and tumor localization of adoptively transferred Melan-A-specifi c T cells in melanoma patients, J. Immunol, vol.170, pp.2161-2169, 2003. ,
Adoptive transfer of tumor-reactive Melan-A-specifi c CTL clones are transcriptionally regulated by MITF in melanocytes and melanoma, Am. J. Pathol, vol.163, pp.333-343, 2005. ,
Melanocyte-specifi c expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator, Mol. Cell. Biol, vol.14, pp.7996-8006, 1994. ,
Highscale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement, Cancer Immunol. Immunother, vol.50, pp.134-140, 2001. ,
High-fold expansion of human cytotoxic T-lymphocytes specifi c for autologous melanoma cells for use in immunotherapy, J. Immunother, vol.10, pp.405-411, 1991. ,
High avidity melanoma-reactive cytotoxic T lymphocytes are effi ciently induced from peripheral blood lymphocytes on stimulation by peptidepulsed melanoma cells, Clin. Cancer Res, vol.6, pp.1459-1467, 2000. ,
A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes, J. Immunol. Methods, vol.95, pp.99-105, 1986. ,
Detection of intracellular cytokines by fl ow cytometry, J. Immunol. Methods, vol.159, pp.197-207, 1993. ,
Tissue-specifi c expression pattern of estrogen receptors (ER): quantifi cation of ER alpha and ER beta mRNA with real-time RT-PCR, APMIS, vol.109, pp.345-355, 2001. ,
Effi cient detection and immunomagnetic sorting of specifi c T cells using multimers of MHC class I and peptide with reduced CD8 binding, Nat. Med, vol.6, pp.707-710, 2000. ,